Antispasmin

Antispasmin is available in the form of yellow tablets, each containing 40 mg of drotaverine hydrochloride. There is also a form of Antispasmin Forte, each tablet containing 80 mg of drotaverine hydrochloride.

The medicine is packaged in blister packs, each containing 20 tablets. This form of release allows for easy and practical administration for patients.

Antispasmin is particularly recommended for adults, adolescents and children over 6 years of age.

Its main use is focused on reducing pain caused by biliary, renal and bladder colic, as well as menstrual pain and uterine spasms.

It is also recognised for its effectiveness in the treatment of digestive disorders such as gastric ulcer, gastritis, enteritis, irritable bowel syndrome and spastic colitis.

This medicine is also effective in relieving headaches characterised by intracranial tension.

The dosage regimen for Antispasmin varies depending on the patient's age group.

For adults and adolescents, the recommended dose is 120-240 mg of drotaverine hydrochloride per day, equivalent to 3-6 tablets taken in 2-3 divided doses.

For children over 6 years of age, the recommended dose is 80-200 mg per day, taken in 2-5 divided doses.

Antispasmin is contraindicated in patients who are allergic to drotaverine hydrochloride or any other ingredient in the tablets. Other contraindications include severe liver, kidney or heart disease.

Also, Antispasmin isn't recommended for kids under 6 years old because there isn't enough info on how safe it is for this age group.

Patients should be extra careful when using Antispasmin if they've been diagnosed with porphyria or have low blood pressure.

In addition, long-term use of this medicine requires monitoring of liver function, as recommended by your doctor.

Antispasmin may cause a number of side effects, although not all patients experience them. Side effects include headaches, dizziness, insomnia, palpitations and low blood pressure. Rare cases of nausea and constipation have also been reported.

It is essential that patients inform their doctor if they experience any severe or unusual side effects.

Antispasmin may interact with other medicines, so it is crucial that patients tell their doctor about any other treatments they are taking.

Antispasmin may interact with medicines containing levodopa, which may alter its effect. Patients who consume alcohol should also be cautious, as it may increase the side effects of the medicine.

In case of overdose with Antispasmin, it is essential that the patient seek medical assistance immediately. Symptoms of overdose may include intensification of the side effects mentioned above, such as dizziness and palpitations. The recommendation of appropriate emergency measures by a specialist is crucial to avoid serious complications.

Anti spasmin should be stored in its original packaging at a temperature below 25°C, away from moisture and light. It is essential that the medicine is kept out of the reach of children to prevent accidental ingestion. Patients should also not dispose of medicines via household waste or household waste disposal systems.

• MDPI, Self-medication with drotaverine among patients with common abdominal symptoms and treatment effectiveness from the perspective of patients and general practitioners
• PubMed, Efficacy and safety of drotaverine hydrochloride in irritable bowel syndrome: A double-blind, placebo-controlled, randomised trial
• PubMed, Effect of drotaverine hydrochloride in acute colicky pain caused by renal and ureteral stones
• Care Hospitals, Drotaverine hydrochloride